Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Becton, Dickinson and Company

Market Cap 39.67B 34.59B 32.04B 29.99B 56.24B 3,743B 56.58B 380B 147B 1,843B 149B 146B 6,398B P/E 2026 *
35.9x
P/E 2027 * 27.7x
Enterprise Value 55.63B 48.5B 44.92B 42.05B 78.86B 5,249B 79.34B 533B 207B 2,584B 209B 204B 8,971B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.73x
Free-Float
74.04%
Yield 2026 *
2.67%
Yield 2027 * 2.72%
1 day+1.67%
1 week-1.55%
Current month-2.13%
1 month-2.02%
3 months-6.59%
6 months-26.39%
Current year-25.81%
1 week 140.63
Extreme 140.63
147.94
1 month 140.63
Extreme 140.63
153.24
Current year 140.63
Extreme 140.63
213.08
1 year 140.63
Extreme 140.63
213.08
3 years 140.63
Extreme 140.63
287.32
5 years 140.63
Extreme 140.63
287.32
10 years 140.63
Extreme 140.63
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-10Sell

Executive/Senior Manager

-1,100 0.0004%
06-01Other

Executive/Senior Manager

0 0%
06-01Free

Executive/Senior Manager

14,258 0.0052%
Change 5-day change 1-year change 3-year change Capi.($)
+1.67%-1.55%-14.51%-43.86% 39.67B
-0.10%+0.26%-33.52%-17.14% 154B
+1.54%-1.07%-8.11%-10.79% 102B
-4.45%+3.12%+61.36%+57.49% 56.51B
-1.90%-3.49%-7.43%+47.34% 52.89B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-44.24% 27.96B
+1.35%-0.26%+51.96%-10.42% 23.17B
-1.53%+1.14%-15.21%-5.72% 20.35B
+1.61%-2.38%-14.03%-5.14% 19.75B
Average -0.14%-1.39%+1.23%-3.61% 52.62B
Weighted average by Cap. -0.20%-1.28%-6.32%-2.86%

Financials

2026 *2027 *
Net sales 19.21B 16.75B 15.51B 14.52B 27.23B 1,812B 27.39B 184B 71.3B 892B 72.09B 70.54B 3,097B 19.71B 17.19B 15.92B 14.9B 27.94B 1,860B 28.11B 189B 73.18B 915B 73.99B 72.4B 3,179B
Net income 1.12B 981M 908M 850M 1.59B 106B 1.6B 10.77B 4.18B 52.23B 4.22B 4.13B 181B 1.45B 1.26B 1.17B 1.1B 2.05B 137B 2.07B 13.88B 5.38B 67.31B 5.44B 5.32B 234B
Net Debt 15.95B 13.91B 12.88B 12.06B 22.62B 1,505B 22.76B 153B 59.24B 741B 59.89B 58.61B 2,573B 14.07B 12.27B 11.36B 10.64B 19.95B 1,328B 20.07B 135B 52.25B 654B 52.82B 51.69B 2,269B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
18/06/26 143.98 $ +1.67% 6,231,987
17/06/26 141.61 $ -2.45% 2,921,247
16/06/26 145.16 $ -0.25% 1,509,925
15/06/26 145.52 $ -0.49% 1,760,185
12/06/26 146.24 $ -0.75% 1,966,917
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
143.98USD
Average target price
180.69USD
Spread / Average Target
+25.50%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!